High rate of colistin dependence in Acinetobacter baumannii

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 8, 2016, Pages 2346-2348

  Hong, Yoon Kyoung ^a   Lee, Ji Young ^a   Wi, Yu Mi ^a   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN DERIVATIVE; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM PLUS SULBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; DISK DIFFUSION; DRUG EXPOSURE; DRUG TREATMENT FAILURE; HUMAN; IN VITRO STUDY; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INTENSIVE CARE UNIT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; SOUTH KOREA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; REPUBLIC OF KOREA;

EID: 84982223874     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw121     Document Type: Letter

References (5)

1. Cai Y, Chai D, Wang R et al. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012; 67: 1607-15.
2. Bartual SG, Seifert H, Hippler C et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4382-90.
3. Selasi GN, Nicholas A, Jeon H et al. Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol 2015; 36: 1-7.
4. Hawley JS, Murray CK, Jorgensen JH. Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Antimicrob Agents Chemother 2007; 51: 4529-30.
5. García-Quintanilla M, Carretero-Ledesma M, Moreno-Martínez P et al. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin, and vancomycin in Acinetobacter baumannii. Int J Antimicrob Agents 2015; 46: 696-702.